
        In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space. 
      

<description>In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.</description>

In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.

Podcast: The British start-up taking psychedelic therapy mainstream

test


        How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.
      

<description>How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.</description>

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

What kind of consistency can industry expect from the FDA post pandemic? 


        Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.  
      

<description>Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.</description>

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.

Chicago emerging as a life science and biopharma hub


        Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.
      

<description>Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.</description>

Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.

Will Biden backed bills boost biosimilars uptake in the US?

Brought to you by the team behind BioPharma-Reporter.com

The Biopharma Pod

Details

Recent Episodes